Welcome to our dedicated page for Agilent Technologies news (Ticker: A), a resource for investors and traders seeking the latest updates and insights on Agilent Technologies stock.
Agilent Technologies Inc. reports developments across analytical and clinical laboratory technologies, including instruments, software, services and scientific expertise used by life science, diagnostics, applied, biopharmaceutical, chemical, advanced materials, clinical lab, environmental, food, forensics, academic and government customers. Company updates commonly address financial results, product launches, laboratory workflows and changes in senior legal, governance and compliance leadership.
Recent Agilent news has highlighted the BioTek Cytation 9 cell imaging multimode reader for cell-based research and high-content screening, cancer research and diagnostics workflows, and FDA-approved companion diagnostic indications for PD-L1 IHC 22C3 pharmDx, including use in identifying certain esophageal or gastroesophageal junction carcinoma patients who may be eligible for KEYTRUDA.
Agilent Technologies (NYSE: A) has appointed August Specht, Ph.D. as its new Chief Technology Officer, effective June 9, 2025. Specht joins Agilent from Thermo Fisher Scientific, where he served as vice president of Global R&D for the Chromatography and Mass Spectrometry Division. With over 25 years of experience in analytical instruments, software, and consumables development, Specht brings extensive expertise in R&D, product management, strategy, and business development from his roles at Thermo Fisher and Varian Instruments.
Specht holds a B.S. in Chemistry from Queen's University, a Ph.D. in Analytical Chemistry from the University of British Columbia, and an MBA from UC Berkeley. Agilent, a global leader in analytical and clinical laboratory technologies, reported revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide.
Agilent Technologies (NYSE: A) has announced significant enhancements to its 8850 Gas Chromatograph (GC), now featuring compatibility with single and triple quadrupole mass spectrometry (MS) systems. The upgraded system stands out as one of the fastest and smallest benchtop GC/MS available, delivering up to 300°C/min oven ramp rates and fast cool-down times.
Key improvements include increased temperature range, compatibility with CTC PAL3 Series 2 Autosampler Systems, Multi-Mode Inlet (MMI), and backflush capabilities. The system achieves 45% less power usage compared to other benchtop GC systems, supporting sustainability goals while maintaining high performance. When integrated with 5977C, 7000E, or 7010D MS systems, it provides enhanced molecular identification and quantification capabilities for chemicals, energy, food, environmental, and forensic laboratories.
Agilent Technologies (NYSE: A) has declared a quarterly dividend of 24.8 cents per share of common stock. The dividend will be paid on July 23, 2025, to shareholders of record as of July 1, 2025. The company notes that future dividend amounts and timing will be subject to board approval.